Vital Therapies, Inc.
|Company Name||Vital Therapies, Inc.|
The Firm is investigating potential claims on behalf of investors of Vital Therapies, Inc. ("Vital" or the "Company") (NASDAQ:VTL) concerning the Company's and its officers' possible violations of federal securities laws. The investigation concerns whether the Company misled investors regarding the future prospects of Vital's ELAD system for the treatment of liver disease. GPM is preparing a lawsuit to recover damages on behalf of Vital investors.
On July 14, 2015, an analyst report published in Seeking Alpha alleged that the Company misled investors regarding the ELAD systems patients' overall survival rate, as Vital included survival data from a patient who received a liver transplant, while no equivalent patient in the control group had received a transplant. This fact was not disclosed in any of the company's prior disclosures. After the publication of this report undermining the Company's clinical data, Vital shares fell $3.61 per share, or 14%, to close on July 15, 2015 at $23.10, thereby damaging investor.
Then on August 21, 2015, the Company announced topline results from its ELAD systems VTI-208 study, and reported that the study, “failed to achieve primary or secondary endpoints of improvement in overall survival.” On this news, the Company’s shares fell $13.55 per share, or over 76%, during intra-day trading on August 24, 2015.
If you purchased Vital shares, have information or would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Casey Sadler, Esquire, of GPM, 1925 Century Park East, Suite 2100, Los Angeles, California 90067 at 310-201-9150, Toll-Free at 888-773-9224 or by email to email@example.com.
Submit Your Information
If you suffered a loss on your Vital Therapies, Inc. investments or would like to inquire about joining an action to recover your loss under the federal securities laws, please complete the form below.
An attorney will contact you at no cost to provide you information about joining the action and answer your questions. Please note that submission of this form does not by itself form an attorney-client relationship nor does filing out this form mean you have joined any lawsuit.